OrthoPediatrics Corp. (KIDS) vs Phathom Pharmaceuticals, Inc. (PHAT)
A side-by-side comparison of OrthoPediatrics Corp. and Phathom Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KIDS
OrthoPediatrics Corp.
$22.71HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PHAT
Phathom Pharmaceuticals, Inc.
$6.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KIDS vs PHAT
growth of $100 · dividends reinvested · last 7yKIDS -37.5% (-6.5%/yr)PHAT -72.8% (-17.0%/yr)KIDS compounded faster over this window
KIDS PHAT
KIDS vs PHAT: by the numbers
- •KIDS is the larger company ($583M vs $549M market cap).
- •Both run net losses; KIDS's is the smaller (-15.72% vs -41.34% net margin).
Metrics side by side
Valuation
| Metric | KIDS | PHAT |
|---|---|---|
| P/S ratio | 2.31 | 2.29 |
| P/B ratio | 1.70 | N/A |
Profitability
| Metric | KIDS | PHAT |
|---|---|---|
| Gross margin | 73.65% | 82.92% |
| Operating margin | -9.01% | -91.36% |
| Net margin | -15.72% | -41.34% |
| ROE | -11.56% | N/A |
| ROIC | -4.97% | -23.45% |
Growth (annualized)
| Metric | KIDS | PHAT |
|---|---|---|
| Revenue CAGR (5Y) | 23.14% | N/A |
| Total return CAGR (5Y) | -18.40% | -26.93% |
Frequently asked
- How have KIDS and PHAT total returns compared?
- Over the past 5 years, KIDS delivered -18.40% and PHAT delivered -26.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
OrthoPediatrics ROEPhathom Pharmaceuticals ROEOrthoPediatrics operating marginPhathom Pharmaceuticals operating marginOrthoPediatrics revenue growthPhathom Pharmaceuticals revenue growthOrthoPediatrics free cash flowPhathom Pharmaceuticals free cash flow
OrthoPediatrics & Phathom Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.